LIVN

LivaNova PLC (NASDAQ:LIVN) is a medical device company founded in 1987 and headquartered in London, United Kingdom. The company was created through the 2015 merger of Cyberonics and Sorin Group, combining expertise in neuromodulation and cardiac surgery technologies. LivaNova designs, develops, manufactures, and sells therapeutic solutions globally, focusing on three core segments: cardiopulmonary products for heart surgery, neuromodulation devices for neurological conditions, and advanced circulatory support systems. The company serves hospitals, medical institutions, and healthcare providers worldwide through direct sales representatives and independent distributors.